Legal Opinion
Icahn School of Medicine at Mount Sinai v. Neurocrine Biosciences, Inc.
District Court, S.D. New York
Decided March 20, 2017No. 15 Civ. 9414PublishedCited by 1 opinion
1Opinion of the Court
OPINION
Sweet, District Judge.
The Plaintiff Icahn School of Medicine at Mount Sinai (“Mt. Sinai” or the “Plaintiff”) has moved pursuant' to F. R. Civ. P. 12(f) to strike Defendant Neurocrine Bios-ciences, Inc.’s (“Neurocrine” or the “Defendant”) affirmative defenses for patent invalidity, non-infringement, and misuse, and moved pursuant to F. R, Civ. P. 12(b)(1) to dismiss Defendant’s corresponding declaratory judgment counterclaims. Based on the conclusions set forth below, Plaintiffs motion to strike affirmative defenses 11-14 and to dismiss counterclaims I-IV is granted.
Prior Proceedings
The…
2Cases cited20 opinions
- Natalia Makarova v. United StatesCourt of Appeals for the Second Circuit · 2000
- Already, LLC v. Nike, Inc.Supreme Court of the United States · 2013
- Lear, Inc. v. AdkinsSupreme Court of the United States · 1969
- Carol Aurecchione v. Schoolman Transportation System, Inc., Classic Coach and Bill Schoolman, Docket No. 04-0561-CvCourt of Appeals for the Second Circuit · 2005
- Association for Molecular Pathology v. Myriad Genetics, Inc.Supreme Court of the United States · 2013
15 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Capri Sun GmbH v. American Beverage CorporationDistrict Court, S.D. New York · 2019